fda import alert glp-1 semaglutide tirzepatide green list 2025 May 4, 2025: New study suggests more adverse events associated with compounded GLP-1s than standard formulations – Partnership for Safe Medicines For more information please visit

Clinical trials have shown impressive results based on dosage levels: 5 mg: Average weight loss of 15% body weight

Patients with pre-existing cardiovascular conditions should be monitored appropriately

Are there side effects

Food and Drug Administration (FDA) about these findings and recommends that people using these untested products contact their physicians for advice and discussion on alternative treatment options. The Study Identified a Chemical Reaction Between Tirzeptide and Vitamin B12 Lillys laboratory testing found that the interaction between tirzepatide and vitamin B12 produced a molecule larger than tirzepatide alone a change that could theoretically affect how the drug is absorbed, distributed, metabolized, or eliminated in the body, the study authors wrote